Literature DB >> 27562552

Multiple sclerosis: Successful trial of amiselimod for multiple sclerosis.

Ian Fyfe.   

Abstract

Entities:  

Year:  2016        PMID： 27562552     DOI： 10.1038/nrneurol.2016.128

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial.

Authors:  Ludwig Kappos; Douglas L Arnold; Amit Bar-Or; John Camm; Tobias Derfuss; Bernd C Kieseier; Till Sprenger; Kristin Greenough; Pingping Ni; Tomohiko Harada
Journal:  Lancet Neurol       Date:  2016-08-16       Impact factor: 44.182
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.